Though I havn't posted in awhile, those of you who have been around this board for awhile know that I have uncannily predicted each and every event in EPCT's history.
I predicted the recent rejection of the ceplene NDA a year ago and for precisely the reason stated by the FDA: the ceplene vs IL2 issue.
Further, I predicted its declining value following the last dilution and reverse split. And another is coming. This company is nothing but a personal piggy bank for a bunch of goons.
Well, I hear your opinion but think you are wrong.
If you read FDA's full decision for not approving MM there was comments about inconcistency in the patient with liver metastases and a general lack of information and data.
FDA might be good, but it is still ODAC that will make the actual review.
Maxim tried to file an unsignificant application (though P-values in subgroups (liver)was OK - but not, just because they acctually were just subgroups).
It is the c o m b i n a t i o n of IL2 and Ceplene that is significant. Additative or synergistic? Please, Jonaustin.
If the FDA persist on having an IL-2 arm then that will impact the new trials in the two other diagnosis that Epicept will design. But EMA, the European authority, will not approve such a design. They have stated that they find that unethical.
That forces Epicept to appeal. A 2 month delay. NP-1 deal will be the brige to 2011.
The price for Ceplene in EU is 51 000 USD. Reimbursement and guidelines will be implemented around year end for 70% of the market according to Meda/Epicept.
STFUP Lars you peace of brainshit
EPCT - after today - is still an all time low !
There is nothing to short you piece of s.hit
Jack Talley shorts it for you you brainbug.
How much do you paid b.itch gettin for showing us off how great EPCT mngmt is doin ?
Jack Talley and Savage Soprano are nothing but a legal
issue, you retarded pumpshit
I missed a prediction on this bunch of goons. My additional prediction, which shall complete the picture: Talley and Savage will face serious legal problems, or even jail for fraudulent self-enrichment.
During the last 3 years they only brought down our share price about 99%, but the same time they increased their personal “income” by +300%, in particular by raising the money for this purpose trough selling shares below market price.
Not happy with your predictions, however could not agree more to your >”This company is nothing but a personal piggy bank for a bunch of goons.>” The only difference, I would prefer the term fraudster.
Stockholders have only to look into Talley's personal balance sheet:
More or less the last two diluting “financing rounds” covered Talley's $ 800,000 “salary” + “incentives” + gift options + stringe benefits..+ salary of the rest + board. .Consequently not much money left for other things.
For that Talley and Savage delivered as their overall “result“(for years) nothing than a permanent dumping of company value and share price, now approx -95 percent.
Since even for such guys any limitation in incompetence should exist a question is, if they dumped intentionally in order to prepare their next self-service deal. We'll see.